FMED
Fidelity Disruptive Medicine ETF
1 year +18.6%Assets$50.16MFidelity Investments
Fee0.51%a year
Yield0.0%
This year+13.8%
5 years-0.0%a year on average
Components71top 10: 34%
Returns
This year
+13.8%
1 year
+18.6%
3 years, yearly
+12.8%
5 years, yearly
-0.0%
10 years, yearly
–
The fund's own total return. Volatility 22.3% over one year, 19.4% over three; Sharpe ratio over three years 0.55.
Sectors
Healthcare100.0%
Regions
North America93.9%
Europe Developed2.8%
United Kingdom1.6%
Asia Emerging0.7%
Asset classes
Stock US91.0%
Cash8.4%
Stock non-US5.6%
Other-7.8%
About the fund
- Issuer
- Fidelity Investments
- Since
- 2020-04-16
- Listed on
- NASDAQ
- ISIN
- US3160921470
- Turnover
- 0% a year
The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.
From the market data provider's fund data, read 2026-10-22. Returns are the fund's own; past returns say nothing certain about future ones. None of this is advice.